Supply of Adenosine Injection (Pharmaceutical Product)

The contract entails the supply and delivery of six packages of Adenosine Injection, identified by NSN 6505016660343, to Joint Base Pearl Harbor-Hickam in Hawaii, with a mandatory delivery completion date of July 14, 2026. The product must fully comply with FDA current Good Manufacturing Practices and Department of Defense packaging standards to ensure quality, safety, and regulatory alignment. This subcontract is issued under the NAICS code 325412, which pertains to pharmaceutical and biological product manufacturing, and is administered by the Defense Logistics Agency on behalf of the Department of Defense. The delivery location and compliance requirements reflect strict logistical and pharmaceutical handling protocols specific to military medical supply chains.